by bradstandish | Oct 27, 2020 | Press Releases
Novo Nordisk Foundation’s innovation initiative, BioInnovation Institute (BII) has awarded EUR 14 million to eight early-stage life science start-ups and research projects. BII has accepted five early-stage start-up companies into the Creation House life science...
by bradstandish | Oct 27, 2020 | Press Releases
The therapeutics start-up 2N Pharma is one of the five new companies in BioInnovation Institute’s Creation House program. The start-up is developing an alternative to today’s treatment of amyotrophic lateral sclerosis (ALS) and is building its case on 10...
by bradstandish | Oct 27, 2020 | Press Releases
The Bioinnovation Institute (BII) have accepted biotech start-up 2N Pharma into its Creation House program awarding the start-up EUR 1.3 million to develop its first in class treatment for the neurodegenerative disease ALS (amyotrophic lateral sclerosis). Also called...
Recent Comments